news 1 month ago

Liquid Biopsy Could help Doctors Predict Breast Cancer Recurrence

Wochit Postables
A new tool could make it easier to predict whether early-stage triple-negative breast cancer will return following chemotherapy. In a new study, researchers used a liquid biopsy called FoundationOne Liquid to test for reoccurrence of the cancer. FoundationOne Liquid uses a blood test to detect circulating tumor DNA (ctDNA). ctDNA values are visible in blood plasma. In studies, researchers were able to detect ctDNA in 63%, of the study participants.